Any US investor looking for a cheat sheet on whether PRR is a good investment need look no further than this new newsletter. Spells it all out and then some.
Cash
Advancing trials
Imminent news
Expanding product range
Better trial results than already FDA approved oncology drugs
...and then the unmentioned Nasdaq listing which will come when it comes.
I too rolled my eyes when I saw another newsletter was out but this has to be the best yet especially if you're a US investor with itchy palms :-)
tuesday - new news , page-9
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |